Qube Research & Technologies (QRT)
RLMD icon

Qube Research & Technologies (QRT)’s Relmada Therapeutics RLMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.55M Buy
653,333
+497,804
+320% +$2.36M 0.01% 1713
2025
Q4 		$751K Buy
+155,529
New +$521K ﹤0.01% 2667
2024
Q3 		– Sell
-56
Closed -$168 – 3976
2024
Q2 		$168 Sell
56
-72,923
-100% -$264K ﹤0.01% 3405
2024
Q1 		$339K Buy
72,979
+68,005
+1,367% +$328K ﹤0.01% 2748
2023
Q4 		$20.6K Buy
4,974
+1,136
+30% +$3.36K ﹤0.01% 3480
2023
Q3 		$11.5K Sell
3,838
-41,691
-92% -$124K ﹤0.01% 3292
2023
Q2 		$112K Buy
+45,529
New +$126K ﹤0.01% 1929

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RLMD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Relmada Therapeutics (RLMD) stake by 320% in Q1 2026, buying an estimated $2.36M and bringing the position to 653,333 shares worth $4.55M. The position accounts for 0.01% of the portfolio, ranked #1713.

Qube Research & Technologies (QRT) first reported a position in RLMD in Q2 2023 and has held it in 7 quarters since. 103 funds tracked by Wall St. Rank hold RLMD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 653,333 shares of Relmada Therapeutics worth $4.55M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 497,804 Relmada Therapeutics shares in Q1 2026, an estimated $2.36M.
  • Relmada Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1713 holding.
  • Qube Research & Technologies (QRT) first reported a position in Relmada Therapeutics in Q2 2023 and has held it in 7 quarters since.
  • 103 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.